Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in CRON — Cronos Group Inc.

CIK 1387508 NEW YORK, NY

Position in CRON

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,252,253
-$1,512,747 QoQ
Shares Held
810,163
-46.0% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#12
of 192 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CRON Over Time

Shares Held

Position Value (USD)

Derivatives in CRON

reported options exposure · as of Sep 30, 2020
CallValue
$28,557
CallShares
5,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $20,247,336 across 16 Drug Manufacturers - Specialty & Generic names. CRON ranks #4 (11.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 CRON
Cronos Group Inc.
This page
810,163 $2,252,253

All Filings in CRON

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,252,253 810,163
2026-03-31 $3,765,000 1,500,000
2025-12-31 $1,535,207 583,729
2025-09-30 $2,209,321 794,720
2025-06-30 $2,592,464 1,357,311
2025-03-31 $3,204,983 1,770,709
2024-12-31 $450,498 223,019
2024-09-30 $77,252 35,275
2024-06-30 $82,190 35,275
2024-03-31 $36,975 14,167
2020-09-30 $28,557 5,700
2020-06-30 $7,212 1,200
2020-03-31 $1,134 200
2020-03-31 $9,072 1,600